Company intelligence / Profile preview
Qymune
San Francisco, California, United Statesqymune.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Qymune is a San Francisco-based biotechnology company focused on developing next-generation T-cell engager (TCE) therapeutics. Utilizing its proprietary Q²TCE (Quiet T Cell Engager) platform, the company designs therapies that achieve potent cytotoxicity while significantly reducing cytokine release, thereby addressing the risk of cytokine release syndrome (CRS). Qymune's lead program, QYM1 (formerly QUM1), is a CD19-targeting T-cell engager being developed for autoimmune diseases (such as myasthenia gravis and rheumatoid arthritis) and B-cell lymphoma. The company has established a multi-phase research collaboration with Daiichi Sankyo to apply its platform to undisclosed oncology targets and was awarded the 2025 AbbVie Golden Ticket at MBC BioLabs.
- Therapeutic areas
- NeurologyOncologyHematologyImmunology
- Modalities
- Bispecific monoclonal antibodyBiologic
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Daiichi SankyoAbbVie
Beyond the preview
Go deeper on Qymune.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qymune.